Live feed16:09:03·2hINSIDERFilingvia QuantisnowChief Development Officer Yeleswaram Krishnaswamy sold $20,160 worth of shares (404 units at $49.90) as part of a pre-agreed trading plan, decreasing direct ownership by 0.16% to 246,022 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
